203 related articles for article (PubMed ID: 25409416)
1. In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancer.
Frik M; Martínez A; Elie BT; Gonzalo O; Ramírez de Mingo D; Sanaú M; Sánchez-Delgado R; Sadhukha T; Prabha S; Ramos JW; Marzo I; Contel M
J Med Chem; 2014 Dec; 57(23):9995-10012. PubMed ID: 25409416
[TBL] [Abstract][Full Text] [Related]
2. The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells.
Montani M; Pazmay GVB; Hysi A; Lupidi G; Pettinari R; Gambini V; Tilio M; Marchetti F; Pettinari C; Ferraro S; Iezzi M; Marchini C; Amici A
Pharmacol Res; 2016 May; 107():282-290. PubMed ID: 27038531
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the Effects and Mechanisms of Anticancer Action of a Ru(II)-Arene Iminophosphorane Compound in Triple Negative Breast Cancer Cells.
Nayeem N; Yeasmin A; Cobos SN; Younes A; Hubbard K; Contel M
ChemMedChem; 2021 Nov; 16(21):3280-3292. PubMed ID: 34329530
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Performance of a Ruthenium-cyclopentadienyl Compound in an Orthotopic Triple Negative Breast Cancer Model.
Mendes N; Tortosa F; Valente A; Marques F; Matos A; Morais TS; Tomaz AI; Gärtner F; Garcia MH
Anticancer Agents Med Chem; 2017; 17(1):126-136. PubMed ID: 27671310
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Localization Studies of the Luminescent Analogue of an Anticancer Ruthenium Iminophosphorane with High Efficacy in a Triple-Negative Breast Cancer Mouse Model.
Miachin K; Del Solar V; El Khoury E; Nayeem N; Khrystenko A; Appelt P; Neary MC; Buccella D; Contel M
Inorg Chem; 2021 Dec; 60(24):19152-19164. PubMed ID: 34846878
[TBL] [Abstract][Full Text] [Related]
7. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
[TBL] [Abstract][Full Text] [Related]
8. Rationally Designed Ruthenium Complexes for Breast Cancer Therapy.
Golbaghi G; Castonguay A
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936496
[TBL] [Abstract][Full Text] [Related]
9. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
10. Potential anticancer heterometallic Fe-Au and Fe-Pd agents: initial mechanistic insights.
Lease N; Vasilevski V; Carreira M; de Almeida A; Sanaú M; Hirva P; Casini A; Contel M
J Med Chem; 2013 Jul; 56(14):5806-18. PubMed ID: 23786413
[TBL] [Abstract][Full Text] [Related]
11. Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?
Nardon C; Brustolin L; Fregona D
Future Med Chem; 2016; 8(2):211-26. PubMed ID: 26807601
[TBL] [Abstract][Full Text] [Related]
12. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E
J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229
[TBL] [Abstract][Full Text] [Related]
13. Amberlite IR-120 (H) mediated "on water" synthesis of fluorescent Ruthenium(II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging.
Mondal A; De S; Maiti S; Sarkar B; Sk AK; Jacob R; Moorthy A; Paira P
J Photochem Photobiol B; 2018 Jan; 178():380-394. PubMed ID: 29195215
[TBL] [Abstract][Full Text] [Related]
14. New water-soluble ruthenium(II) cytotoxic complex: biological activity and cellular distribution.
Morais TS; Santos FC; Jorge TF; Côrte-Real L; Madeira PJ; Marques F; Robalo MP; Matos A; Santos I; Garcia MH
J Inorg Biochem; 2014 Jan; 130():1-14. PubMed ID: 24145065
[TBL] [Abstract][Full Text] [Related]
15. Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]
Purushothaman B; Arumugam P; Ju H; Kulsi G; Samson AAS; Song JM
Eur J Med Chem; 2018 Aug; 156():747-759. PubMed ID: 30048924
[TBL] [Abstract][Full Text] [Related]
16. New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent.
Guerriero A; Oberhauser W; Riedel T; Peruzzini M; Dyson PJ; Gonsalvi L
Inorg Chem; 2017 May; 56(10):5514-5518. PubMed ID: 28443659
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances on Dark and Light-Activated Cytotoxity of Imidazole-Containing Ruthenium Complexes.
Liu P; Jia J; Zhao Y; Wang KZ
Mini Rev Med Chem; 2016; 16(4):272-89. PubMed ID: 26586123
[TBL] [Abstract][Full Text] [Related]
18. Transport of the Ruthenium Complex [Ru(GA)(dppe)
Naves MA; Graminha AE; Vegas LC; Luna-Dulcey L; Honorato J; Menezes ACS; Batista AA; Cominetti MR
Mol Pharm; 2019 Mar; 16(3):1167-1183. PubMed ID: 30633527
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems.
Ferraro MG; Piccolo M; Misso G; Maione F; Montesarchio D; Caraglia M; Paduano L; Santamaria R; Irace C
Cells; 2020 Jun; 9(6):. PubMed ID: 32517101
[TBL] [Abstract][Full Text] [Related]
20. Water-Soluble Ruthenium(II) Complexes with Chiral 4-(2,3-Dihydroxypropyl)-formamide Oxoaporphine (FOA): In Vitro and in Vivo Anticancer Activity by Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Induction of Tumor Cell Apoptosis.
Chen ZF; Qin QP; Qin JL; Zhou J; Li YL; Li N; Liu YC; Liang H
J Med Chem; 2015 Jun; 58(11):4771-89. PubMed ID: 25988535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
